Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The lung-gut crosstalk in respiratory and inflammatory bowel disease. | Front Cell Infect Microbiol | 2023 | 37680747 | PubTator, text mining | PubMed |
| Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD. | Front Cell Dev Biol | 2023 | 37645250 | PubTator, text mining | PubMed |
| Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes. | Cell Biosci | 2023 | 37641145 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies. | Biomedicines | 2023 | 37626745 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer. | Front Immunol | 2023 | 37622111 | PubTator, text mining | PubMed |
| Myositis as an Extraintestinal Manifestation of Ulcerative Colitis: A Case Report and Literature Review. | Cureus | 2023 | 37614279 | PubTator, text mining | PubMed |
| An update on the safety of long-term vedolizumab use in inflammatory bowel disease. | Expert Opin Drug Saf | 2023 | 37610086 | PubTator, text mining | PubMed |
| Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials. | Clin Exp Gastroenterol | 2023 | 37609124 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analysis: Association between Preoperative Ustekinumab and Surgical Complications in Crohn's Disease Patients. | Eur Surg Res | 2023 | 37598662 | PubTator, text mining | PubMed |
| IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function. | Cell Rep | 2023 | 37598341 | PubTator, text mining | PubMed |
| A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology. | Nat Commun | 2023 | 37596262 | PubTator, text mining | PubMed |
| Status of integrin subunit alpha 4 promoter DNA methylation in colorectal cancer and other malignant tumors: a systematic review and meta-analysis. | Res Pharm Sci | 2023 | 37593168 | PubTator, text mining | PubMed |
| The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis. | J Transl Med | 2023 | 37592303 | PubTator, text mining | PubMed |
| Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis. | Clin Exp Immunol | 2023 | 37565620 | PubTator, text mining | PubMed |
| Interaction Between Blood Vasculatures and Lymphatic Vasculatures During Inflammation. | J Inflamm Res | 2023 | 37560514 | PubTator, text mining | PubMed |
| Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk. | Hepatol Commun | 2023 | 37555943 | PubTator, text mining | PubMed |
| Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma. | Cell Rep | 2023 | 37537844 | PubTator, text mining | PubMed |
| Characterizing the Immune Microenvironment and Neoantigen Landscape of Hürthle Cell Carcinoma to Identify Potential Immunologic Vulnerabilities. | Cancer Res Commun | 2023 | 37529400 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. | Front Immunol | 2023 | 37529035 | PubTator, text mining | PubMed |
| Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease. | Intest Res | 2023 | 37519211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=8